Alpha-9 Oncology Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
82
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$175M
- Investors
-
17
Alpha-9 Oncology General Information
Description
Developer of radiopharmaceuticals designed to treat cancer cells with precision. The company utilizes peptide engineering and iterative design to create selective and potent molecules, for solid and hematologic malignancies by using proprietary technology, enabling cancer patients to receive targeted and personalized treatments.
Contact Information
Website
www.a9oncology.comCorporate Office
- 27 East 7th Avenue
- Suite 300
- Vancouver, British Columbia V5T 1M4
- Canada
Corporate Office
- 27 East 7th Avenue
- Suite 300
- Vancouver, British Columbia V5T 1M4
- Canada
Alpha-9 Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 23-Oct-2024 | $175M | Completed | Clinical Trials - Phase 1 | ||
| 4. Early Stage VC (Series B) | 30-Jun-2022 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC (Series A) | 28-Apr-2021 | Completed | Clinical Trials - Phase 1 | |||
| 2. Seed Round | 30-Jun-2020 | $77K | $77K | Completed | Stealth | |
| 1. University Spin-Out | 01-Jan-2018 | Completed | Stealth |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Alpha-9 Oncology Comparisons
Industry
Financing
Details
Alpha-9 Oncology Competitors (15)
One of Alpha-9 Oncology’s 15 competitors is ExCellThera, a Accelerator/Incubator Backed company based in Montreal, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ExCellThera | Accelerator/Incubator Backed | Montreal, Canada | ||||
| Navidea Biopharmaceuticals | Corporate Backed or Acquired | Columbus, OH | ||||
| AsherBio | Venture Capital-Backed | South San Francisco, CA | ||||
| MaveriX Oncology | Venture Capital-Backed | Palo Alto, CA | ||||
| RadioMedix | Venture Capital-Backed | Houston, TX |
Alpha-9 Oncology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alpha-9 Oncology Patents
Alpha-9 Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026206827-A1 | Combination therapies for treatment of melanoma | Pending | 24-Mar-2025 | ||
| WO-2026152218-A1 | Compositions targeting neurotensin receptor and uses thereof | Pending | 15-Jan-2025 | ||
| US-12728175-B2 | Gastrin-releasing peptide receptor (grpr)-targeted compounds and uses thereof | Active | 13-Sep-2024 | ||
| US-20260077073-A1 | Gastrin-releasing peptide receptor (grpr)-targeted compounds and uses thereof | Active | 13-Sep-2024 | ||
| US-20260284243-A1 | Gastrin-releasing peptide receptor (grpr)-targeted compounds and uses thereof | Pending | 13-Sep-2024 | A61K51/088 |
Alpha-9 Oncology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alpha-9 Oncology Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aberdeen Investments (Scotland) | Asset Manager | Minority | ||
| Andreessen Horowitz | Venture Capital | Minority | ||
| Ascenta Capital | Venture Capital | Minority | ||
| Delos Capital Partners | Venture Capital | Minority | ||
| Digitalis Ventures | Venture Capital | Minority |
Alpha-9 Oncology FAQs
-
When was Alpha-9 Oncology founded?
Alpha-9 Oncology was founded in 2018.
-
Where is Alpha-9 Oncology headquartered?
Alpha-9 Oncology is headquartered in Vancouver, Canada.
-
What is the size of Alpha-9 Oncology?
Alpha-9 Oncology has 82 total employees.
-
What industry is Alpha-9 Oncology in?
Alpha-9 Oncology’s primary industry is Drug Discovery.
-
Is Alpha-9 Oncology a private or public company?
Alpha-9 Oncology is a Private company.
-
What is Alpha-9 Oncology’s current revenue?
The current revenue for Alpha-9 Oncology is .
-
How much funding has Alpha-9 Oncology raised over time?
Alpha-9 Oncology has raised $261M.
-
Who are Alpha-9 Oncology’s investors?
Aberdeen Investments (Scotland), Andreessen Horowitz, Ascenta Capital, Delos Capital Partners, and Digitalis Ventures are 5 of 17 investors who have invested in Alpha-9 Oncology.
-
Who are Alpha-9 Oncology’s competitors?
ExCellThera, Navidea Biopharmaceuticals, AsherBio, MaveriX Oncology, and RadioMedix are some of the 15 competitors of Alpha-9 Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
